Trial Profile
Treatment with abatacept or rituximab targets T follicular helper cells in patients with primary Sjogren's syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Rituximab (Primary)
- Indications Sjogren's syndrome
- Focus Therapeutic Use
- 08 Feb 2016 New trial record